🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Stada Arzneimittel AG — Licensed Medicines

37 medicines held by Stada Arzneimittel AG on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 37 products held by Stada Arzneimittel AG
MedicineActive substanceLicence holderStatus
APO-go AMPOULES 10 mg/ml Solution for Injection or Infusion *Abbreviated to APO-go in the text
PA0593/043/002
Apomorphine hydrochloride Stada Arzneimittel AG Not marketed
APO-go POD 5 mg/ml solution for infusion in cartridge
PA0593/042/004
Apomorphine hydrochloride hemihydrate Stada Arzneimittel AG Marketed
APO-go® PEN 10 mg/ml Solution for Injection** Abbreviated to APO-go in the text
PA0593/043/001
Apomorphine hydrochloride Stada Arzneimittel AG Marketed
APO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe
PA0593/043/003
Apomorphine hydrochloride Stada Arzneimittel AG Marketed
Gotenfia 100 mg solution for injection in pre-filled syringe
EU/1/25/2009/003-004
Golimumab Stada Arzneimittel AG
Gotenfia 50 mg solution for injection in pre-filled syringe
EU/1/25/2009/001-002
Golimumab Stada Arzneimittel AG
Hukyndra 20 mg solution for injection in pre-filled syringe
EU/1/21/1589/010
Adalimumab Stada Arzneimittel AG
Hukyndra 40 mg solution for injection in pre-filled pen
EU/1/21/1589/004-006
Adalimumab Stada Arzneimittel AG
Hukyndra 40 mg solution for injection in pre-filled syringe
EU/1/21/1589/001-003
Adalimumab Stada Arzneimittel AG
Hukyndra 80 mg solution for injection in pre-filled pen
EU/1/21/1589/008-009
Adalimumab Stada Arzneimittel AG
Hukyndra 80 mg solution for injection in pre-filled syringe
EU/1/21/1589/007
Adalimumab Stada Arzneimittel AG
Kefdensis 60 mg solution for injection in pre-filled syringe
EU/1/25/1980/001
Denosumab Stada Arzneimittel AG
Kinpeygo 4 mg modified-release hard capsules
EU/1/22/1657/001
Budesonide micronised Stada Arzneimittel AG
Libmyris
EU/1/21/1590/001-006
Adalimumab Stada Arzneimittel AG
Libmyris 80 mg solution for injection in pre-filled syringe
EU/1/21/1590/007
Adalimumab Stada Arzneimittel AG
Movymia 20 micrograms/80 microliters solution for injection
EU/1/16/1161/001-002
Teriparatide Stada Arzneimittel AG
Oyavas 25 mg/mL concentrate for solution for infusion
EU/1/20/1510/001-002
Bevacizumab Stada Arzneimittel AG
Silapo
EU/1/07/432/17-19
Epoetin zeta Stada Arzneimittel AG
Silapo
EU/1/07/432/7-16
Epoetin zeta Stada Arzneimittel AG
Silapo 1000 IU/0.3 ml Solution for injection
EU/1/07/432/1-6
Epoetin zeta Stada Arzneimittel AG
Sildenafil STADA 100mg Chewable tablets
PA0593/047/003
Sildenafil citrate Stada Arzneimittel AG Not marketed
Sildenafil STADA 25 mg Chewable tablets
PA0593/047/001
Sildenafil citrate Stada Arzneimittel AG Not marketed
Sildenafil STADA 50 mg Chewable tablets
PA0593/047/002
Sildenafil citrate Stada Arzneimittel AG Not marketed
Sildenafil STADA Arzneimittel AG 100 mg Chewable tablets
PA0593/048/003
Sildenafil citrate Stada Arzneimittel AG Not marketed
Sildenafil STADA Arzneimittel AG 25 mg Chewable tablets
PA0593/048/001
Sildenafil citrate Stada Arzneimittel AG Not marketed
Sildenafil STADA Arzneimittel AG 50 mg chewable tablets
PA0593/048/002
Sildenafil citrate Stada Arzneimittel AG Not marketed
Tofidence 20 mg/ml Concentrate for solution for infusion
EU/1/24/1825/001-006
Tocilizumab Stada Arzneimittel AG
Usgena 130 mg concentrate for solution for infusion
EU/1/25/1987/005
Ustekinumab Stada Arzneimittel AG
Usgena 45 mg solution for injection
EU/1/25/1987/001
Ustekinumab Stada Arzneimittel AG
Usgena 45 mg solution for injection in pre-filled syringe
EU/1/25/1987/002
Ustekinumab Stada Arzneimittel AG
Usgena 90 mg solution for injection in pre-filled syringe
EU/1/25/1987/003-004
Ustekinumab Stada Arzneimittel AG
Uzpruvo 130 mg concentrate for solution for infusion
EU/1/23/1784/005
Ustekinumab Stada Arzneimittel AG
Uzpruvo 45 mg solution for injection in pre-filled syringe
EU/1/23/1784/001
Ustekinumab Stada Arzneimittel AG
Uzpruvo 90 mg solution for injection in pre-filled syringe
EU/1/23/1784/004
Ustekinumab Stada Arzneimittel AG
Ximluci 10 mg/mL solution for injection
EU/1/22/1691/001
Ranibizumab Stada Arzneimittel AG
Ximluci 10 mg/mL solution for injection
EU/1/22/1691/002
Ranibizumab Stada Arzneimittel AG
Zvogra 120 mg solution for injection
EU/1/25/1981/001-003
Denosumab Stada Arzneimittel AG
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.